How Conditional FDA Approval of Credelio Quattro-CA1 Could Impact Elanco Animal Health (ELAN) Investors

Elanco Animal Health recently received conditional FDA approval for Credelio Quattro-CA1, the first companion animal treatment targeting New World screwworm infestations in dogs, reinforcing its ...

Elanco's Credelio Quattro™-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World ...

Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) for Credelio Quattro™-CA1 (lotilaner, moxidectin, ...
Nasdaq

Jaguar Health Completes Filing of New Animal Drug Application for Conditional Approval of Canalevia-CA1 (Crofelemer) to Treat Chemotherapy-Induced Diarrhea in Dogs, Clearing ...

Canalevia™-CA1 is the first and only oral plant-based prescription drug candidate for CID in dogsJaguar kicks off educational awareness contest in honor of International Jaguar Day; Click here to ...
eFeedLink

US FDA approves MSD Animal Health's EXZOLT™ CATTLE-CA1 for treatment of New World screwworm

MSD Animal Health, a division of Merck & Co., Inc., on December 4 announced the US Food and Drug Administration (FDA) has ...